Expectations trend
FY2028 · fiscal year ending 2028-10-31 · fmp
$10.50 → $10.49 · observed estimates
THE BANK OF NOVA SCOTIA (BNS)
NYSEFinancialsBanks - DiversifiedSnapshot 2026-11-04
$91.77-4.83%
Close 2026-11-05 · 1-day change
NYSEFinancialsBanks - DiversifiedSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for BNS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
earnings per share growth to at least $8.29 in FY26 | Scotiabank grows earnings steadily with EPS around $8.29 in 2026. | Intact | EPS falls below $8.29 in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-10-31 · fmp
$10.50 → $10.49 · observed estimates
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a financial-sector exposure, with its near-term setup tied partly to interest rates and sector earnings momentum. The thesis state is insufficient because there is not enough recent financial-performance history to assess the business trend.
The evidence gives no valuation level or clear account of market expectations, so it does not support calling BNS cheap, fair, or expensive versus peers. Fragility is rated low, but that does not establish what expectations are already reflected.
Near-term miss risk is described as low, though the evidence notes that BNS and industry peers have missed lately and that BNS had a deep miss in its recent history. The sector backdrop is neutral, and the snapshot provides too little company-specific information to assess the multi-year fundamental trajectory.
A key near-term swing factor is whether the Fed begins cutting rates, which the evidence says could weigh on financial stocks. Sector momentum also depends on whether JPM, BAC, and HSBC continue beating earnings and guiding higher, or instead miss and guide lower.
For the next 1 to 3 years, the BNS thesis remains uncertain: the evidence points to moderate risk and sector-sensitive drivers, but does not establish a company-specific fundamental trend or valuation expectations. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in THE BANK OF NOVA SCOTIA's published investment case. The stated target is interest rates flat; inflation near 4.25% YoY. |
| Intact |
| interest rates rise sharply or inflation exceeds 6% YoY |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
revenue growth to about $39.6 billion in FY26 | It expands revenue to about $39.6 billion. | Intact | revenue falls below $39 billion in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
successful integration of AI partnerships to enhance competitiveness | A supporting condition in THE BANK OF NOVA SCOTIA's published investment case. The stated target is maintain or expand AI partnership benefits. | Intact | partnerships fail to deliver competitive advantage or are discontinued | Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$45.23B → $45.16B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-11-01 | $10.50 | $45,229,964,466 | 3 / 4 |
| 2026-11-02 | $10.52 | $45,279,798,349 | 3 / 4 |
| 2026-11-03 | $10.51 | $45,234,978,710 | 3 / 4 |
| 2026-11-04 | $10.49 | $45,159,017,368 | 3 / 4 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 5 Buy / Strong Buy · 8 Hold · 1 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Dec 1, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.